Breaking News Instant updates and real-time market news.

PTCT

PTC Therapeutics

$27.56

0.87 (3.26%)

16:32
04/12/18
04/12
16:32
04/12/18
16:32

PTC Therapeutics: Underwriters exercise option to purchase 600,00 shares

PTC Therapeutics announced that the underwriters of its previously announced public offering of 4M shares of its common stock, which closed on April 3, 2018, have exercised in full their option to purchase an additional 600,000 shares at the public offering price less underwriting discounts and commissions. After giving effect to the closing with respect to the additional shares, the total number of shares sold by PTC in the offering increased to 4.6M shares. All of the shares in the offering were sold by PTC. PTC's aggregate net proceeds from the offering are expected to be approximately $117.9M, after deducting underwriting discounts and commissions and estimated offering expenses. Credit Suisse and Citigroup acted as lead book-running managers for the offering. RBC Capital Markets also acted as a book-running manager.

  • 17

    Apr

  • 03

    May

PTCT PTC Therapeutics
$27.56

0.87 (3.26%)

02/21/18
SBSH
02/21/18
NO CHANGE
Target $35
SBSH
Buy
PTC Therapeutics price target raised to $35 from $24 at Citi
Citi analyst Joel Beatty raised his price target for PTC Therapeutics to $35 on expectations that outside the U.S. Translarna sales and U.S. Emflaza sales growth will continue in 2018. Further, the analyst sees the potential for upside from additional Phase 2 data on spinal muscular atrophy agent RG7916 and from a trial design update on plans to generate dystrophin production data for Translarna in pursuit of accelerated approval. Beatty added U.S. Translarna sales back into his model, probability-adjusted at 10%, after yesterday's update from PTC that FDA will allow an accelerated approval pathway to be pursued for the drug. The analyst keeps a Buy rating on the shares.
04/03/18
LEHM
04/03/18
DOWNGRADE
LEHM
Underweight
PTC Therapeutics downgraded to Underweight from Equal Weight at Barclays
04/03/18
LEHM
04/03/18
DOWNGRADE
Target $26
LEHM
Underweight
Barclays downgrades PTC Therapeutics to Underweight with $26 target
Barclays analyst Gena Wang downgraded PTC Therapeutics to Underweight from Equal Weight while raising her price target for the shares to $26 from $24. The stock closed the trading day up 15c to $26.12. The analyst sees limited upside to 2018 revenue expectations and believes PTC's growth trajectory is fully priced in at current valuation levels.
04/04/18
04/04/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PTC Therapeutics (PTCT) downgraded to Underweight from Equal Weight at Barclays with analyst Gena Wang saying she sees limited upside to 2018 revenue expectations and believes PTC's growth trajectory is fully priced in at current valuation levels. 2. Cloudera (CLDR) downgraded to Neutral from Overweight at JPMorgan and to Hold from Buy at Deutsche Bank. 3. Domino's Pizza (DPZ) downgraded to Hold from Buy at Deutsche Bank with analyst Brett Levy citing valuation. 4. Virtusa (VRTU) downgraded to Hold from Buy at SunTrust with analyst Frank Atkins saying while Virtusa stock has risen 166% since November of 2016, future upside may be more limited. 5. ResMed (RMD) downgraded to Neutral from Buy at Citi with analyst Victor Windeyer citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, Reference Link

TODAY'S FREE FLY STORIES

LRAD

LRAD Corporation

$2.83

0.02 (0.71%)

16:55
08/14/18
08/14
16:55
08/14/18
16:55
Hot Stocks
LRAD Corporation says 'well positioned to achieve record fiscal year revenues' »

"LRAD is in a much…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 23

    Aug

LRAD

LRAD Corporation

$2.83

0.02 (0.71%)

16:54
08/14/18
08/14
16:54
08/14/18
16:54
Hot Stocks
Breaking Hot Stocks news story on LRAD Corporation »

LRAD Corporation reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 23

    Aug

LRAD

LRAD Corporation

$2.83

0.02 (0.71%)

16:53
08/14/18
08/14
16:53
08/14/18
16:53
Earnings
LRAD Corporation reports Q3 EPS 0c, one estimate 0c »

Reports Q3 revenue $7.5M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 23

    Aug

CDNA

CareDx

$16.87

-0.13 (-0.76%)

16:50
08/14/18
08/14
16:50
08/14/18
16:50
Hot Stocks
CareDx CFO Michael Brian Bell sells 12,500 shares of company stock »

CareDx CFO Michael Brian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

VNDA

Vanda Pharmaceuticals

$21.60

0.15 (0.70%)

16:46
08/14/18
08/14
16:46
08/14/18
16:46
Hot Stocks
Vanda Pharmaceuticals wins denial of petition for rehearing on Fanapt »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$193.08

-1.03 (-0.53%)

16:45
08/14/18
08/14
16:45
08/14/18
16:45
Recommendations
Home Depot analyst commentary  »

Home Depot underlying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

FANG

Diamondback Energy

$133.75

1.84 (1.39%)

16:45
08/14/18
08/14
16:45
08/14/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Diamondback Energy »

Diamondback Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$98.41

1.32 (1.36%)

, UTX

United Technologies

$132.40

0.23 (0.17%)

16:42
08/14/18
08/14
16:42
08/14/18
16:42
Hot Stocks
Pershing Square adds Lowe's, cuts stake in ADP »

Bill Ackman's…

LOW

Lowe's

$98.41

1.32 (1.36%)

UTX

United Technologies

$132.40

0.23 (0.17%)

MDLZ

Mondelez

$41.87

-0.03 (-0.07%)

ADP

ADP

$141.17

1.48 (1.06%)

QSR

Restaurant Brands

$62.20

0.355 (0.57%)

CMG

Chipotle

$493.33

8.97 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 22

    Aug

  • 07

    Sep

  • 11

    Sep

  • 12

    Sep

  • 24

    Sep

DXC

DXC Technology

$86.56

2.02 (2.39%)

16:41
08/14/18
08/14
16:41
08/14/18
16:41
Hot Stocks
DXC Technology awarded $400M contract by Wisconsin DHS »

The Wisconsin Department…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

16:39
08/14/18
08/14
16:39
08/14/18
16:39
General news
API crude inventories for week of August 10 »

API reports that crude…

CSOD

Cornerstone OnDemand

$52.59

0.48 (0.92%)

16:35
08/14/18
08/14
16:35
08/14/18
16:35
Recommendations
Cornerstone OnDemand analyst commentary  »

Cornerstone OnDemand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 20

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 27

    Aug

  • 28

    Aug

  • 29

    Aug

  • 04

    Sep

  • 06

    Sep

  • 07

    Sep

  • 12

    Sep

  • 12

    Sep

ATNM

Actinium Pharmaceuticals

$0.62

0.003 (0.49%)

16:34
08/14/18
08/14
16:34
08/14/18
16:34
Conference/Events
Actinium Pharmaceuticals to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 04

    Sep

PRSP

Perspecta

$21.64

-0.31 (-1.41%)

16:34
08/14/18
08/14
16:34
08/14/18
16:34
Earnings
Perspecta sees FY18 pro forma revenue $4.150B-$4.250B, consensus $4.2B »

Sees FY19 adjusted EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

FCN

FTI Consulting

$80.32

0.33 (0.41%)

16:33
08/14/18
08/14
16:33
08/14/18
16:33
Syndicate
Breaking Syndicate news story on FTI Consulting »

FTI Consulting files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRSP

Perspecta

$21.64

-0.31 (-1.41%)

16:32
08/14/18
08/14
16:32
08/14/18
16:32
Hot Stocks
Perspecta reports Q1 adjusted EPS 54c, consensus 46c »

Reports Q1 revenue $793M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

SBBP

Strongbridge Biopharma

$6.25

0.3 (5.04%)

16:31
08/14/18
08/14
16:31
08/14/18
16:31
Syndicate
Strongbridge Biopharma files to sell 9M ordinary shares »

Cowen and Stifel are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HWC

Hancock Whitney

$51.40

0.6 (1.18%)

16:31
08/14/18
08/14
16:31
08/14/18
16:31
Hot Stocks
Hancock Whitney names Christopher Ziluca as new Chief Credit Officer »

Hancock Whitney has named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRI

Atrion

$656.00

9 (1.39%)

16:31
08/14/18
08/14
16:31
08/14/18
16:31
Hot Stocks
Atrion increases quarterly cash dividend by 13% »

Atrion Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIK

Tel-Instrument

$2.60

(0.00%)

16:31
08/14/18
08/14
16:31
08/14/18
16:31
Hot Stocks
Tel-Instrument receives NYSE non-compliance letter »

Tel Instrument…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/14/18
08/14
16:30
08/14/18
16:30
Options
Preliminary option volume of 16.1M today »

Preliminary option volume…

DLPN

Dolphin Entertainment

$2.96

(0.00%)

16:29
08/14/18
08/14
16:29
08/14/18
16:29
Earnings
Dolphin Entertainment reports Q2 EPS (1c), consensus 2c »

Reports Q2 revenue $5.2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

BK

BNY Mellon

$50.97

0.825 (1.65%)

, GE

General Electric

$12.35

-0.09 (-0.72%)

16:29
08/14/18
08/14
16:29
08/14/18
16:29
Hot Stocks
Trian Fund boosts BNY Mellon, lowers stake in Wendy's »

Nelson Peltz's Trian…

BK

BNY Mellon

$50.97

0.825 (1.65%)

GE

General Electric

$12.35

-0.09 (-0.72%)

MDLZ

Mondelez

$41.87

-0.03 (-0.07%)

WEN

Wendy's

$17.84

0.48 (2.77%)

SYY

Sysco

$74.19

1.47 (2.02%)

PG

Procter & Gamble

$81.31

-0.21 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 07

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

VRAY

ViewRay

$9.89

-0.01 (-0.10%)

16:28
08/14/18
08/14
16:28
08/14/18
16:28
Syndicate
ViewRay files to sell $125M of common stock »

Morgan Stanley and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

LMB

Limbach Holding

$10.70

0.11 (1.04%)

16:26
08/14/18
08/14
16:26
08/14/18
16:26
Earnings
Limbach Holding raises FY18 revenue view to $530-$550M from $520M-$540M »

Consensus $527.77M. Now…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

MRSN

Mersana Therapeutics

$12.75

0.04 (0.31%)

16:26
08/14/18
08/14
16:26
08/14/18
16:26
Earnings
Mersana Therapeutics reports Q2 EPS (54c), consensus (58c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 15

    Aug

  • 04

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.